These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 28438863

  • 1. The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.
    Turgut S, Ilhan M, Turan S, Karaman O, Yaylim I, Kucukhuseyin O, Tasan E.
    In Vivo; 2017; 31(3):357-363. PubMed ID: 28438863
    [Abstract] [Full Text] [Related]

  • 2. Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?
    Ilhan M, Kahraman OT, Turan S, Turgut S, Karaman O, Zeybek U, Shukurov S, Yaylim I, Tasan E.
    Ann Endocrinol (Paris); 2015 Oct; 76(5):614-9. PubMed ID: 26514951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
    Tuna G, Küçükhüseyin O, Arıkan S, Kaytan Sağlam E, Güler E, Cacına C, Oztop O, Turan S, Korkmaz G, Yaylım I.
    DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
    [Abstract] [Full Text] [Related]

  • 5. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML, Xu YX, Qian J, Wang FH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [Abstract] [Full Text] [Related]

  • 6. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D.
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [Abstract] [Full Text] [Related]

  • 7. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4123-9. PubMed ID: 17634539
    [Abstract] [Full Text] [Related]

  • 8. MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population.
    Ezzikouri S, El Feydi AE, Afifi R, El Kihal L, Benazzouz M, Hassar M, Marchio A, Pineau P, Benjelloun S.
    Cancer Detect Prev; 2009 Jul 15; 32(5-6):380-5. PubMed ID: 19233569
    [Abstract] [Full Text] [Related]

  • 9. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H, Sümbül AT, Bayram S, Bekar A, Akgöllü E.
    Cancer Epidemiol; 2010 Aug 15; 34(4):448-52. PubMed ID: 20447891
    [Abstract] [Full Text] [Related]

  • 10. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
    Yan L, Na W, Shan K, Xiao-Wei M, Wei G, Shu-Cheng C.
    Int J Gynecol Cancer; 2008 Aug 15; 18(1):30-5. PubMed ID: 17466040
    [Abstract] [Full Text] [Related]

  • 11. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
    Abderrahmane R, Louhibi L, Moghtit FZ, Boubekeur A, Benseddik K, Boudjema A, Benrrahal F, Aberkane M, Fodil M, Saidi-Mehtar N.
    Pathol Oncol Res; 2015 Jul 15; 21(3):629-35. PubMed ID: 25537146
    [Abstract] [Full Text] [Related]

  • 12. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, Bharadwaj M.
    DNA Cell Biol; 2013 Jan 15; 32(1):19-27. PubMed ID: 23210739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development.
    Cingeetham A, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V.
    Asian Pac J Cancer Prev; 2015 Jan 15; 16(7):2707-12. PubMed ID: 25854351
    [Abstract] [Full Text] [Related]

  • 15. Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.
    Yilmaz M, Tas A, Donmez G, Kacan T, Silig Y.
    Asian Pac J Cancer Prev; 2018 Apr 27; 19(4):1059-1062. PubMed ID: 29699057
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul 27; 11(7):640-5. PubMed ID: 12101111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.